:Chemotherapy-induced hyperpigmentation
{{Infobox medical condition (new)
| name = Chemotherapy-induced hyperpigmentation
| synonyms =
| image =
| caption =
| pronounce =
| field = Dermatology
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}
Chemotherapy-induced hyperpigmentation is caused by many chemotherapeutic agents (especially the antibiotics bleomycin, and daunorubicin) and the alkylating agents (cyclophosphamide and busulfan).James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. {{ISBN|0-7216-2921-0}}.{{rp|132}}
See also
References
{{reflist}}
External links
{{Medical resources
| DiseasesDB =
| ICD10 = {{ICD10|Y|43|1|y|40}}-{{ICD10|Y|43|3|y|40}}
| ICD9 = {{ICD9|E933.1}}
| ICDO =
| OMIM =
| MedlinePlus =
| eMedicineSubj =
| eMedicineTopic =
| MeshID =
}}
{{External causes of morbidity and mortality}}
{{Cutaneous-condition-stub}}